Your session is about to expire
← Back to Search
CivaSheet for Lung Cancer
Study Summary
This trial will test a new cancer treatment device to see if it is safe and effective. The device uses active components of standard devices in a new way, which may reduce the amount of radiation to healthy tissue while giving a therapeutic dose to diseased tissue.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a lung spot that may be non-small cell lung cancer.I am preparing for surgery.My tumor is 7 cm or smaller, as shown by a CT scan.I haven't had cancer, except for non-melanoma skin or in-situ cancer, in over 5 years.I am not pregnant.My cancer is in the early stages (stage I or II).My lung cancer is in the upper part of my left or right lung.
- Group 1: CivaSheet Directional LDR Brachytherapy
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is CivaSheet a substance that people can use without fear?
"CivaSheet's safety is estimated to be a 2. Although there is some data supporting CivaSheet's safety, none of it speaks to the medication's efficacy."
How many individuals are being given this experimental treatment?
"According to the information available on clinicaltrials.gov, this research is actively looking for participants. The trial was originally posted on March 13th, 2019 and updated as recently as May 23rd, 2022. Currently, the study is enrolling 40 patients from 3 different locations."
Is it currently possible to sign up for this clinical trial?
"From what is published on clinicaltrials.gov, it seems that this particular trial is still open to enrolling patients. The listing was first created on March 13th, 2019 with the most recent update being from May 23rd, 2022. They are currently looking for 40 individuals total who will participate at 3 different locations."
Share this study with friends
Copy Link
Messenger